
Pioneering AI Drug Discovery | Recursion
All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.
Our AI Drug Discovery & Development Story | Recursion
Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to …
Press Releases & Recursion News | Recursion
Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …
AI-Driven Drug Discovery Insights | Recursion
Dec 4, 2025 · Explore Recursion's latest blog posts on AI, automation, and molecular modeling in drug discovery. Stay informed with cutting-edge insights!
Recursion Announces Completion of NVIDIA-Powered BioHive-2, …
May 13, 2024 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, …
Recursion Pharmaceuticals, Inc. - Preliminary Phase 1b/2 Data for …
May 4, 2025 · Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry …
Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!
Accelerating AI Drug Discovery with Open Source Datasets
May 28, 2025 · That’s why we’ve not only been building massive fit-for-purpose datasets at Recursion, but releasing smaller open source versions of these datasets to accelerate the …